Iowa State Bank’s Rani Therapeutics RANI Stock Holding History

Iowa State Bank’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,862	Closed	-$181K	–	121
2022 Q3	$181K	Buy	+18,862	New	+$200K	0.05%	112

Other funds holding RANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return

ASGS

Alpha Square Group S New York $103M AUM 63.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TWA

TPB Wealth Advisors San Antonio, Texas $183M AUM 9.21% 1-Year Est. Return

Iowa State Bank's RANI Position: Q4 2022 in Review

Iowa State Bank sold out of Rani Therapeutics (RANI) in Q4 2022, closing a stake of 18,862 shares — an estimated $181K sold.

Iowa State Bank first reported a position in RANI in Q3 2022 and held it in 1 quarter. The position peaked at $181K in Q3 2022. 34 funds tracked by Wall St. Rank hold RANI as of Q4 2022.

Iowa State Bank reported no remaining Rani Therapeutics position as of Q4 2022 after selling out during the quarter.
Iowa State Bank sold 18,862 Rani Therapeutics shares in Q4 2022, an estimated $181K.
Iowa State Bank first reported a position in Rani Therapeutics in Q3 2022 and held it in 1 quarter.
Iowa State Bank's Rani Therapeutics position peaked at $181K in Q3 2022.
34 funds tracked by Wall St. Rank held Rani Therapeutics as of Q4 2022.

Based on Iowa State Bank's 13F filing for Q4 2022, filed 6 Jan 2023.